Intended Learners

These activities are intended for community and academic clinicians who care for patients with solid tumors, including medical oncologists, surgical oncologists, radiation oncologists, OB/GYNs, surgeons, NPs/PAs, and other healthcare professionals (e.g., oncology nurses, pharmacists, navigators, physicians-in-training). 

Learning Objectives

After completing this activity, participants should be able to:

• Identify the appropriate use and recommended methods of biomarker/genomic testing across solid tumors to enhance clinical decision making and personalize patient care.
• Examine efficacy and safety criteria used to select first-line therapy for solid tumor cancers.
• Analyze the benefits and limitations of using sequential targeted therapies for disease resistance or progression across various cancer types. 
• Explore the challenges and potential barriers of how new therapeutic options can be incorporated into the community oncologist’s practice setting.

Provider Statement

Provided by HMP Education, an HMP Global Company. 

Accreditation Statement

In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Note: This statement is not an indication of approved credits. Please see below for full accreditation details, including credit types and totals, for this activity.

PHYSICIANS

HMP Education designates this live activity for a maximum of 7.5 AMA PRA Category1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

PHARMACISTS

This live, knowledge-based activity (Universal Activity JA0006201-0000-26-129-L01-P) has been approved for a maximum of 7.5 contact hours (0.75 CEUs). 

Note: The certificate is not the official record of your participation in the activity. The official record of credit will be the information in the CPE Monitor system. Following ACPE Policy, credit must be transmitted to NABP through CPE Monitor within 60 days from the date you complete this CPE activity.  

NURSES

This continuing nursing education live activity awards 7.5 contact hours.  

Provider approved by the California Board of Registered Nursing, Provider #18006, for 7.5 contact hours. 

NURSE PRACTITIONERS

American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category1 Credits™ from organizations accredited by the ACCME. 

PHYSICIANS ASSOCIATES/ASSISTANTS

HMP Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This live activity is designated for 7.5 AAPA Category 1 credits. PAs should claim only the credit commensurate with the extent of their participation. 

INTERNATIONAL RECOGNITION  

Visit this link for countries and regions have reciprocity with the ACCME.  

Visit this link for additional countries that accept ACCME-accredited continuing medical education (CME). 

Requirements for Credit 

To be eligible for documentation of credit for each session attended, learners must participate in the activity and complete the session(s) and overall conference evaluations, as well as post-test(s), if applicable. Participants who complete the evaluation online within 30 days of the conference will receive documentation of credit. Your certificate may not load if you are accessing it from a smartphone or if your browser settings do not allow a new tab/window to open.  

Once a certificate has been claimed, physicians and pharmacists may elect for credits to be submitted on their behalf to their boards via additional fields that will appear within the Claim Certificate page. Credits must be submitted through this process to be reported to the American Board of Surgery and the National Association of Boards of Pharmacy. 

ADA Statement

HMP Education complies with the legal requirements of the Americans with Disabilities Act, and the rules and regulations thereof. Any participant in this educational activity who needs accommodation(s) may submit a request to the support team.

Non-Accredited Innovation Theaters

Each Innovation Theater is a non-accredited presentation. The opinions and recommendations expressed do not necessarily reflect the views of HMP Global. This presentation is not intended or eligible for continuing education (CME/CE) credits. By having your badge scanned or entering the virtual room, you opt-in to share/receive information with/from the sponsor. Please speak with a Great Debates Solid Tumors representative if you do not wish to opt in.  

Food and beverages are provided by HMP Global. Great Debates Solid Tumors attendees have paid for their meal as part of their conference registration fee. 

Commercial Support

Supported by educational grants from AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; Corcept Therapeutics, Inc.; Incyte Corporation; Johnson & Johnson; Stemline Therapeutics Inc, a Menarini Company; and Verastem, Inc.